Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1CONCERTA

02 1COVERA-HS

03 1DITROPAN XL

04 1ENVARSUS XR

05 1EXALGO

06 1FELODIPINE

07 1GLIPIZIDE

08 1HYDROMORPHONE HYDROCHLORIDE

09 1INVEGA

10 4METHYLPHENIDATE HYDROCHLORIDE

11 1MORPHINE SULFATE

12 1OXYBUTYNIN CHLORIDE

13 1OXYCONTIN

14 4PALIPERIDONE

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

METHYLPHENIDATE HYDROCHLORIDE

Drug : METHYLPHENIDATE HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 213473

Country : US

Patented : No

Granules India

02

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

PALIPERIDONE

Drug : PALIPERIDONE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 202645

Country : US

Patented : No

blank

03

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Drug : HYDROMORPHONE HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 212133

Country : US

Patented : No

blank

04

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

METHYLPHENIDATE HYDROCHLORIDE

Drug : METHYLPHENIDATE HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 211009

Country : US

Patented : No

blank

05

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

METHYLPHENIDATE HYDROCHLORIDE

Drug : METHYLPHENIDATE HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 210818

Country : US

Patented : No

blank

06

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

METHYLPHENIDATE HYDROCHLORIDE

Drug : METHYLPHENIDATE HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 206726

Country : US

Patented : No

blank

07

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

PALIPERIDONE

Drug : PALIPERIDONE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 212807

Country : US

Patented : No

blank

08

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

PALIPERIDONE

Drug : PALIPERIDONE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 204452

Country : US

Patented : No

blank

09

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

OXYBUTYNIN CHLORIDE

Drug : DITROPAN XL

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 20897

Country : US

Patented : No

blank

10

PH HEALTH
arrow
Aus. Peptide Conference
Not Confirmed
PH HEALTH
Country
arrow
Aus. Peptide Conference
Not Confirmed

GLIPIZIDE

Drug : GLIPIZIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 76159

Country : US

Patented : No

blank